Elutia

ELUT · NASDAQ

$0.8105−$0.0047 (−0.58%)TodayMarket closed ·
Prev close $0.8152

About ELUT

The company is headquartered in Silver Spring, Maryland and currently employs 25 full-time employees. The company went IPO on 2020-10-08.

Employees
25
Headquarters
Silver Spring, Maryland
Listed
Oct 8, 2020
Sector
Health Care
Industry
Biotechnology
Website
elutia.com

ELUT key statistics

Market cap
35.90M
Price-earnings ratio
0.94
Dividend yield
—
Average volume
448.11K
Volume
72.20K
Open price
$0.805
High today
$0.8438
Low today
$0.7628
52 Week high
$1.39
52 Week low
$0.50

Elutia (ELUT) at a glance

As of Oct 20, 2026, Elutia (ELUT) shares are priced at $0.8105, giving the company a market cap of 35.90M and a price-to-earnings ratio of 0.94.

Today the stock has traded between $0.7628 and $0.8438. The current price is 6.3% above the day's low and 3.9% below its high.

Volume so far is 72.20K shares, below the average of 448.11K shares a day.

Over the past year Elutia has ranged from $0.50 to $1.39, and now sits 35% of the way up that range.

Elutia met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.17 per share against an estimate of -$0.153.

ELUT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 314.5% on average.

  1. Q3 FY24: reported -$0.33 per share against an estimate of -$0.4488
  2. Q4 FY24: reported -$0.26 per share against an estimate of -$0.255
  3. Q1 FY25: reported -$0.10 per share against an estimate of -$0.2091
  4. Q2 FY25: reported -$0.23 per share against an estimate of -$0.1734
  5. Q3 FY25: reported -$0.09 per share against an estimate of -$0.1581
  6. Q4 FY25: reported $1.48 per share against an estimate of -$0.1428
  7. Q1 FY26: reported -$0.17 per share against an estimate of -$0.153
  8. Q2 FY26: reported -$0.17 per share against an estimate of -$0.153

ELUT news

  • Vandana Singh

    Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity

  • Press releaseGlobe Newswire

    A Reno Biotech Just Rang the Nasdaq Bell — Here's Why the Whole Regenerative-Medicine Tape Is Worth Watching

  • Exploring Elutia's Earnings Expectations

  • Earnings Scheduled For November 6, 2025

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Earnings Scheduled For May 8, 2025

  • Press releaseACCESSWIRE

    SWK Holdings Provides Portfolio Update

Similar companies

Companies in the same industry as Elutia

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.